New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas

14 February 2020

Augusto Mitidieri – Most Influential CEO Europe 2019 for Humancentric Driven Innovation

31 January 2020

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

31 January 2020

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region

27 January 2020

Helsinn appoints Eric Cornut and Lonnie Moulder to the Board of Directors

13 January 2020

Helsinn to present a scientific poster on acute care use following CINV prophylaxis with agents in breast cancer patients at the San Antonio Breast Cancer Symposium (SABCS) 2019

16 December 2019

3° trimestre 2019: industria farmaceutica ed energia guidano la crescita del PIL

28 November 2019

Helsinn Advanced Synthesis, Biasca: Reduces CO2 emissions by 80% and unveils the new anticancer plant

22 November 2019

Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai

14 November 2019

Helsinn attends 4th Annual Sino-Swiss Business Awards

7 November 2019